Reported Saturday, Lilly's Taltz And Zepbound Combination Achieves 31.7% ACR50 And 10% Weight Reduction Versus 0.8% For Taltz Alone In TOGETHER-PsA Trial - Eli Lilly (NYSE:LLY)
Airfind news item
Published on March 30, 2026.
The combination of Taltz and Zepbound can achieve 31.7% ACR50 and 10% Weight Reduction in their combined efforts, compared to 0.8% for Talton alone. The article also mentions that the company's Taltanist, who are currently in possession of the world's largest drug company, is considered the best in the world.
Read Original Article